655 related articles for article (PubMed ID: 33444083)
1. Increased metformin dosage suppresses pro-inflammatory cytokine levels in systemic circulation and might contribute to its beneficial effects.
Amoani B; Sakyi SA; Mantey R; Laing EF; Ephraim RD; Sarfo-Katanka O; Koffie S; Obese E; Afranie BO
J Immunoassay Immunochem; 2021 May; 42(3):252-264. PubMed ID: 33444083
[TBL] [Abstract][Full Text] [Related]
2. Effects of acarbose and metformin on the inflammatory state in newly diagnosed type 2 diabetes patients: a one-year randomized clinical study.
Mo D; Liu S; Ma H; Tian H; Yu H; Zhang X; Tong N; Liao J; Ren Y
Drug Des Devel Ther; 2019; 13():2769-2776. PubMed ID: 31496653
[TBL] [Abstract][Full Text] [Related]
3. Elevated Serum TNF-
Alzamil H
J Obes; 2020; 2020():5076858. PubMed ID: 32089876
[TBL] [Abstract][Full Text] [Related]
4. Variations in levels of IL-6 and TNF-α in type 2 diabetes mellitus between rural and urban Ashanti Region of Ghana.
Darko SN; Yar DD; Owusu-Dabo E; Awuah AA; Dapaah W; Addofoh N; Salifu SP; Awua-Boateng NY; Adomako-Boateng F
BMC Endocr Disord; 2015 Sep; 15():50. PubMed ID: 26391589
[TBL] [Abstract][Full Text] [Related]
5. [Effect of metformin on the expression of tumor necrosis factor-α, Toll like receptors 2/4 and C reactive protein in obese type-2 diabetic patients].
Andrews M; Soto N; Arredondo M
Rev Med Chil; 2012 Nov; 140(11):1377-82. PubMed ID: 23677182
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacogenetic features of the effect of metformin in patients with coronary heart disease in the presence of metabolic syndrome and type 2 diabetes mellitus in terms of PPAR-gamma2 gene polymorphism].
Lavrenko AV; Shlykova OA; Kutsenko LA; Mamontova TV; Kaĭdashev IP
Ter Arkh; 2012; 84(9):35-40. PubMed ID: 23091851
[TBL] [Abstract][Full Text] [Related]
7. The inflammatory status score including IL-6, TNF-α, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus.
Daniele G; Guardado Mendoza R; Winnier D; Fiorentino TV; Pengou Z; Cornell J; Andreozzi F; Jenkinson C; Cersosimo E; Federici M; Tripathy D; Folli F
Acta Diabetol; 2014 Feb; 51(1):123-31. PubMed ID: 24370923
[TBL] [Abstract][Full Text] [Related]
8. Effects of rosiglitazone/metformin fixed-dose combination therapy and metformin monotherapy on serum vaspin, adiponectin and IL-6 levels in drug-naïve patients with type 2 diabetes.
Kadoglou NP; Kapelouzou A; Tsanikidis H; Vitta I; Liapis CD; Sailer N
Exp Clin Endocrinol Diabetes; 2011 Feb; 119(2):63-8. PubMed ID: 21031343
[TBL] [Abstract][Full Text] [Related]
9. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
Freemark M; Bursey D
Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
[TBL] [Abstract][Full Text] [Related]
10. Chemerin and apelin are positively correlated with inflammation in obese type 2 diabetic patients.
Yu S; Zhang Y; Li MZ; Xu H; Wang Q; Song J; Lin P; Zhang L; Liu Q; Huang QX; Wang K; Hou WK
Chin Med J (Engl); 2012 Oct; 125(19):3440-4. PubMed ID: 23044303
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of IL-32 in patients with type 2 diabetes mellitus and its relationship with TNF-α and IL-6.
Fadaei R; Bagheri N; Heidarian E; Nouri A; Hesari Z; Moradi N; Ahmadi A; Ahmadi R
Cytokine; 2020 Jan; 125():154832. PubMed ID: 31479874
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory cytokines and chemokines, skeletal muscle and polycystic ovary syndrome: effects of pioglitazone and metformin treatment.
Ciaraldi TP; Aroda V; Mudaliar SR; Henry RR
Metabolism; 2013 Nov; 62(11):1587-96. PubMed ID: 23958241
[TBL] [Abstract][Full Text] [Related]
13. Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients.
Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Ragonesi PD; Querci F; Franzetti IG; Gadaleta G; Ciccarelli L; Piccinni MN; D'Angelo A; Cicero AF
Metabolism; 2010 Jun; 59(6):887-95. PubMed ID: 20015525
[TBL] [Abstract][Full Text] [Related]
14. The effect of the ingestion of Ginkgo biloba extract (EGb 761) on the pharmacokinetics of metformin in non-diabetic and type 2 diabetic subjects--a double blind placebo-controlled, crossover study.
Kudolo GB; Wang W; Javors M; Blodgett J
Clin Nutr; 2006 Aug; 25(4):606-16. PubMed ID: 16698134
[TBL] [Abstract][Full Text] [Related]
15. Adiponectin, TNF-α and inflammatory cytokines and risk of type 2 diabetes: A systematic review and meta-analysis.
Liu C; Feng X; Li Q; Wang Y; Li Q; Hua M
Cytokine; 2016 Oct; 86():100-109. PubMed ID: 27498215
[TBL] [Abstract][Full Text] [Related]
16. Profiling immuno-metabolic mediators of vitamin B12 deficiency among metformin-treated type 2 diabetic patients in Ghana.
Sakyi SA; Laing EF; Mantey R; Kwarteng A; Owiredu EW; Dadzie RE; Amoani B; Opoku S; Afranie BO; Boakye D
PLoS One; 2021; 16(3):e0249325. PubMed ID: 33784336
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and pharmacodynamics of metformin in healthy subjects and patients with noninsulin-dependent diabetes mellitus.
Sambol NC; Chiang J; O'Conner M; Liu CY; Lin ET; Goodman AM; Benet LZ; Karam JH
J Clin Pharmacol; 1996 Nov; 36(11):1012-21. PubMed ID: 8973990
[TBL] [Abstract][Full Text] [Related]
18. Imbalanced low-grade inflammation and endothelial activation in patients with type 2 diabetes mellitus and erectile dysfunction.
Araña Rosaínz Mde J; Ojeda MO; Acosta JR; Elías-Calles LC; González NO; Herrera OT; García Álvarez CT; Rodríguez EM; Báez ME; Seijas EÁ; Valdés RF
J Sex Med; 2011 Jul; 8(7):2017-30. PubMed ID: 21554550
[TBL] [Abstract][Full Text] [Related]
19. Type 2 diabetes and metabolic syndrome - adipokine levels and effect of drugs.
Farooq R; Amin S; Hayat Bhat M; Malik R; Wani HA; Majid S
Gynecol Endocrinol; 2017 Jan; 33(1):75-78. PubMed ID: 27705028
[TBL] [Abstract][Full Text] [Related]
20. The Impact of Pharmacotherapy of Type 2 Diabetes Mellitus on IL-1β, IL-6 and IL-10 Secretion.
Borowska M; Dworacka M; Wesołowska A; Winiarska H; Krzyżagórska E; Dworacki G
Pharmacology; 2016; 97(3-4):189-94. PubMed ID: 26854669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
